Category: Anticoagulation
The Time is Now: Equity in the Prescribing of DOACs for NVAF
Devin L. Lavender, PharmD, BCPS, BCACP
Despite new recommendations and data, some populations are not prescribed DOACs for NVAF as often as they should.
Finding Undiagnosed Atrial Fibrillation: Why, What, Who and How
James S. Kalus, PharmD, FASHP
Pharmacists can identify undiagnosed atrial fibrillation and prevent stroke. A plan for screening for atrial fibrillation.
VTE Prophylaxis for Medically Ill Patients: The History of Pharmacologic Warfare
John Fanikos, R.Ph., MBA
Take a stroll through history exploring the therapeutic options for VTE prophylaxis in medically ill patients
Laboratory Monitoring of DOAC Levels: Any Value in That?
Jason R. Vilar, Pharm.D., BCCCP
A discussion of standard and alternative laboratory methods to measure levels of direct-acting oral anticoagulants
Making Peripheral Disease the Center of Attention
Zachary Stacy, Pharm.D., M.S., FCCP, BCPS
While peripheral arterial disease affects more than 8 million U.S. patients with the potential for significant cardiovascular complications and death, disease state awareness remains low.
Who and When: Re-initiating Anticoagulants After a Bleed
James S. Kalus, Pharm.D., FASHP
A discussion of the complexities of re-initiating anticoagulants after a bleeding event caused by anticoagulants